Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer.
Journal: Cancer immunology research
Published: March 05, 2026
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9+ monocyte-macrophage programming and durable anti-tumor immunity in triple negative breast cancer.
Journal: bioRxiv : the preprint server for biology
Published: February 12, 2026
Enhancing conventional biopsies: ultrasound-guided percutaneous bone marrow biopsy and aspiration.
Journal: Journal of ultrasound
Published: August 08, 2025
Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers.
Journal: bioRxiv : the preprint server for biology
Published: June 26, 2025
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers.
Journal: Nature communications
Published: April 30, 2025
CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC.
Journal: bioRxiv : the preprint server for biology
Published: May 07, 2024
CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer.
Journal: JCI insight
Published: May 07, 2024
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
Journal: bioRxiv : the preprint server for biology
Published: October 09, 2023
Hydrogel-Embedded Precision-Cut Lung Slices Model Lung Cancer Premalignancy Ex Vivo.
Journal: Advanced healthcare materials
Published: July 14, 2023
Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
Journal: The Journal of clinical investigation
Published: May 22, 2023
Precision Cut Lung Slices as a Preclinical Model for Non-Small Cell Lung Cancer Chemoprevention.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: January 02, 2023
PPARgamma agonism inhibits progression of premalignant lesions in a murine lung squamous cell carcinoma model.
Journal: International journal of cancer
Published: December 03, 2021
Last Updated: 09/26/2026